Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced Patient Monitoring Will Boost Clinical Labs, “Futurist” Tells AACC

This article was originally published in The Gray Sheet

Executive Summary

Clinical laboratories can tap into an emerging growth opportunity by offering technical support to manufacturers of remote and continuous patient monitors, according to University of Virginia School of Medicine's Jeff Goldsmith, PhD

You may also be interested in...



Cardiac Monitor Maker Courts Payment Latitude Prior To Home-Use Launch

Guidant says it will release a home-use version of its Latitude advanced patient management (APM) system upon gaining a CPT code to drive reimbursement

DTC, IT Lab Services Perceived As IVD Industry Drivers By AACC Speakers

Over the next three years, in vitro diagnostics manufacturers will increasingly provide administrative services to laboratories as a component of their business offerings, Bayer Diagnostics President Rolf Classon predicted March 21

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel